Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy

Código QR

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy

Patients with type 2 diabetes mellitus (T2DM) often feature resistance to endogenous and exogenous insulin which is a serious problemto overcome. Current paper presents clinical case of T2DM characterized by marked insulin resistance, where high dosage regimenfailed to compensate carbohydrate metabo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ekaterina Viktorovna Artemova, Irina Vladimirovna Kononenko, Olga Mikhailovna Smirnova, Alexander Yur'evich Mayorov
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2012
Materias:	diabetes mellitus insulin resistance continuous subcutaneous insulin infusion insulin pump therapy Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/095b7c5de9244846a782179bf639d604
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Insulin pump therapy in type 1 diabetes mellitus: education effectiveness and quality of life
por: Lyudmila Ibragimovna Ibragimova, et al.
Publicado: (2012)

Intraperitoneal insulin infusion: on the way to the artificial pancreas
por: Vladimir Aleksandrovich Karpel'ev, et al.
Publicado: (2015)

The 5th International Conference on Advanced Technologies Treatments for Diabetes (ATTD 2012),2012 February 8-11, Barcelona (Spain)
por: Yury Ivanovich Filippov, et al.
Publicado: (2012)

Selected aspects of insulin pump therapy and continuous glucose monitoring in real time (in relation to the letter of E.D.Gorbachev)
por: Yury Ivanovich Filippov, et al.
Publicado: (2010)

Evaluation of glycaemic profile variability as a basis for insulin therapy strategy in pregnant women with type 1 diabetes
por: Alena V. Tiselko, et al.
Publicado: (2019)

Development and in silico validation of the PID-algorithm for the artificial pancreas with intraperitoneal insulin delivery
por: Vladimir A. Karpelyev, et al.
Publicado: (2018)

Insulin-induced lipohypertrophy: clinical and ultrasound characteristics
por: Vadim V. Klimontov, et al.
Publicado: (2018)

Psychosocial aspects of the usage of modern technologies in diabetes mellitus
por: Oleg G. Motovilin, et al.
Publicado: (2019)

Lypohypertrophy in patients receiving insulin therapy: state of the art
por: Natalya Ivanovna Volkova, et al.
Publicado: (2011)

Dose adjustment in insulin pump therapy: optimization of bolus calculator settings
por: Yury Ivanovich Filippov, et al.
Publicado: (2012)

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2015)

Rapid Desensitization for Insulin Allergy in Type 1 Diabetes Using an Insulin Pump: A Case Report and Literature Review
por: Kristy Tian, MBBS, MRCP, MMed, et al.
Publicado: (2021)

Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
por: Elena Efimovna Petryaykina, et al.
Publicado: (2009)

Modern technology for the treatment of type 1 diabetes mellitus with end-stage renal failure
por: Yulia Alexandrovna Krupinova, et al.
Publicado: (2015)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
por: Ivan Ivanovich Dedov, et al.
Publicado: (2014)

Diabetes mellitus due to biliary recurrent pancreatitis. Case report
por: Elena Alexandrovna Kharlashina, et al.
Publicado: (2011)

The experience with the use of insulin pump therapy in children and adolescents with type 1 diabetes mellitus
por: Nina Viktorovna Bolotova, et al.
Publicado: (2010)

In vitro fertilization as a method of infertility treatment in women with type 1 diabetes mellitus
por: Elena V. Misharina, et al.
Publicado: (2018)

Alterations in the Levels of Circulating and Endothelial Progenitor Cells Levels in Young Adults with Type 1 Diabetes: A 2-Year Follow-Up from the Observational METRO Study
por: Longo M, et al.
Publicado: (2020)

Reported insulin pump temperature fluctuations lack clinical relevance
por: Dokken BB, et al.
Publicado: (2017)

Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention
por: Vadim V. Klimontov, et al.
Publicado: (2020)

Insulin resistance in pathogenesis of type 2 diabetes mellitus
por: Alexander Yur'evich Mayorov
Publicado: (2011)

Insulin signaling proteins in pancreatic islets of insulin-resistant rats induced by glucocorticoid
por: De Paula,Flávia MM, et al.
Publicado: (2011)

Modern approach to the evaluation of the pharmacokinetics and pharmacodynamics of biosimilar recombinant human insulin and insulin analogues in I phase clinical study
por: Irina A. Proskurina, et al.
Publicado: (2016)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
por: Elena V. Buryukova, et al.
Publicado: (2017)

Age-adjustment of insulin pump settings in children and adolescents with type 1 diabetes mellitus
por: Dmitriy Nikitich Laptev, et al.
Publicado: (2013)

Effective and safe control of glycemia with insulin Apidra - the recipe for success of type 2 diabetes prophylaxis
por: Elena Valer'evna Biryukova
Publicado: (2011)

A Rare Case of Subcutaneous Insulin Resistance Presumed to be due to Paraneoplastic Process in Pancreatic Adenocarcinoma
por: Kacey Chae, MD, et al.
Publicado: (2021)

The first and only combination of basal and prandial insulin analogs degludec and aspart: the position of Russian endocrinologists
por: M. V. Shestakova, et al.
Publicado: (2021)

Insulin/weight ratio may serve as a predictor of success during insulin pump therapy in type 2 diabetes patients: a proof-of-concept study
por: Shmuel Levit, et al.
Publicado: (2015)

Hypoglycemia in type 2 diabetes patients treated with insulin: the advantages of continuous glucose monitoring
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)

New concepts of glucose-induced insulin secretion in the development of type 2 diabetes: clinical implications
por: Ivan Ivanovich Dedov, et al.
Publicado: (2015)

Molecular Mechanisms of Insulin Resistance Development
por: Vsevolod Arsen'evich Tkachuk, et al.
Publicado: (2014)

Barriers to Uptake of Insulin Technologies and Novel Solutions
por: Pauley ME, et al.
Publicado: (2021)

Pengaruh Latihan Fisik terhadap Perbaikan Resistensi Insulin
por: Devitya Angielevi Sukarno
Publicado: (2021)

Subcutaneous adipose tissue browning, serum orexin-A, and insulin resistance following aerobic exercise in high-fat diet obesity male wistar rats
por: Ebrahim Moslehi, et al.
Publicado: (2021)

Insulin pump therapy in children with diabetes mellitus: practice of Krasnoyarsk Krai
por: Tatiana Evgen'evna Taranushenko, et al.
Publicado: (2012)

Prospective study of efficacy and safety of insulin pump therapy in children and adolescents
por: Andrey Olegovich Emel'yanov, et al.
Publicado: (2010)

Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30
por: Elena Viktorovna Surkova
Publicado: (2013)

Modern basal insulins: an ongoing story or the start of a new era?
por: Ivan Ivanovich Dedov
Publicado: (2015)